Archives
-
IAM LC vs LEKC in Pulmonary Permeability
2026-10-06
A 2024 Journal of Chromatography A study provides a direct comparison of immobilised artificial membrane liquid chromatography and liposome electrokinetic capillary chromatography for modelling drug–membrane partitioning. Its findings indicate that LEKC may better reflect pulmonary permeability for many compounds, whereas IAM LC offers broader compound coverage and stronger prospects for robust, high-throughput screening.
-
DNase I (RNase-free) for Translational Precision
2026-10-06
A thought-leadership perspective on how DNA-removal strategy supports interpretable RNA workflows, human-cell studies, and translational reproducibility—without overstating what current evidence proves.
-
AM 281 and the CB1–CREB–GLT-1 Axis
2026-10-05
Recent mouse traumatic brain injury research positions CB1 signaling as a potential regulator of astrocytic GLT-1 and glutamate-related cognitive dysfunction. This thought-leadership article interprets how AM 281 can support mechanistic CB1 cannabinoid receptor antagonist research while distinguishing reported findings from translational hypotheses, product claims, and evidence limitations.
-
Pronase E in Ferroptosis Evidence Analysis
2026-10-05
Pronase E is a broad-spectrum protease mixture with a distinctive role in ferroptosis research: not as proof of mechanism, but as an analytical reagent for examining protein evidence. This article separates sample-preparation utility from causal interpretation in a recent gramine study of the CUL3–MTDH axis.
-
C8-HSL in Microbial Signaling and Lung Cancer
2026-10-04
N-octanoyl-L-Homoserine lactone, or C8-HSL, is a quorum-sensing molecule associated with Gram-negative bacterial communication. A 2026 FASEB Journal study reports that C8-HSL promoted proliferation, migration, and invasion in H460 lung cancer cells through PI3K/AKT/ERK-associated signaling, while important questions about exposure, specificity, clinical relevance, and validation remain unresolved.
-
How Near-Death Cells Acquire Metastatic States
2026-10-03
Conod, Silvano, and Ruiz i Altaba report that tumor cells surviving impending death can acquire stable prometastatic properties rather than merely represent a pre-existing aggressive subpopulation. Their Cell Reports study links this transition to ER stress, PERK–CHOP signaling, GLI and NANOG-associated reprogramming, and cytokine-mediated recruitment of neighboring cells, providing a framework for understanding how metastatic ecosystems may emerge after cytotoxic stress.
-
AG-221 (Enasidenib): From 2-HG to AML Strategy
2026-10-02
AG-221 (Enasidenib) is more than an IDH2 inhibitor: it is a translational tool for connecting oncometabolite suppression, leukemia cell differentiation, and metabolic dependencies. This article interprets recent CD44 findings and outlines a practical strategy for designing mechanistically informative IDH2-mutant AML studies.
-
Reactive Oxygen Species Assay Kit in Nanomedicine
2026-10-01
Discover how the Reactive Oxygen Species Assay Kit and DCFH-DA fluorescent probe can map redox responses in live-cell nanomedicine experiments. This guide connects ROS measurement with ROS-responsive drug release, cuproptosis interpretation, assay controls, and mechanistic validation.
-
AM 281: CB1 Cannabinoid Receptor Antagonist
2026-10-01
AM 281 enables selective interrogation of CB1 signaling in receptor, astrocyte, and traumatic brain injury workflows. Its strongest use-case is mechanistic neuropharmacology: connecting CB1 activity with CREB phosphorylation, GLT-1 regulation, glutamate excitotoxicity, and cognitive outcomes.
-
DLL3 Research Strategy: From Detection to Translation
2026-09-30
A translational framework for using the Anti-DLL3 Antibody (Dragonfly patent anti-DLL3) to connect DLL3 protein detection, mechanistic studies, and preclinical evaluation with emerging transient DLL3-directed CAR-T strategies in small cell lung cancer.
-
Cyclic di-GMP, HipH, and Biofilm Persistence
2026-09-30
Liao and colleagues identify cyclic di-GMP as a small-molecule antitoxin that restrains the genotoxic toxin HipH during early biofilm development. Their results connect adhesion-stage signaling with DNA double-strand breaks, genome instability, and antibiotic persistence, providing a mechanistic framework for biofilm resilience beyond simple nutrient limitation or diffusion models.
-
AM 281: CB1 Antagonist Research Guide
2026-09-29
AM 281 is a potent CB1 cannabinoid receptor antagonist and inverse agonist with nanomolar CB1 affinity. Its reported ability to reverse CB1–CREB–GLT-1 changes after traumatic brain injury makes it a useful tool for memory impairment research, while its selectivity and solubility impose important experimental limits.
-
DNase I (RNase-free): Translational Precision
2026-09-29
A mechanistic and strategic guide to using DNase I (RNase-free) for DNA removal in RNA extraction, RT-PCR, in vitro transcription, and chromatin workflows while protecting experimental interpretability.
-
BMX-IN-1: From Phosphosite to Host-Directed Assays
2026-09-28
BMX-IN-1 is a selective BMX kinase inhibitor that connects covalent target engagement with lysosomal, infection, and cancer-cell phenotypes. This article presents a phosphosite-to-phenotype framework for designing better BMX assays and interpreting results in tuberculosis and oncology research.
-
Bleeding Risk During Extended VTE Anticoagulation
2026-09-28
A prospective multinational cohort study assessed bleeding risk during extended anticoagulation after unprovoked or weakly provoked venous thromboembolism. Modified ACCP, VTE-BLEED, and HAS-BLED scores separated higher-risk from lower-risk patients, while the simpler CHAP model offered a promising approach that still requires external validation.